65 Results

People

  1. Drilon
    Drilon
  2. Li
    Li
  3. Kris
    Kris
  4. Offin
    Offin
  5. Riely
    Riely
  6. Rudin
    Rudin
  7. Arcila
    Arcila
  8. Ni
    Ni
  9. Berger
    Berger
  10. Hyman
    Hyman

Groups

  1. Department of Medicine (65)
  2. Epidemiology and Biostatistics (65)
  3. Solid Tumor Oncology Division (65)
  4. Thoracic Oncology (65)
  5. Biostatistics Service (55)
  6. GSK Faculty (46)
  7. Human Oncology and Pathogenesis Program (36)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (30)
  9. Radiology, Department of (25)
  10. Tow Center for Developmental Oncology (TCDO) (24)
  1. "Alexander Drilon"
  2. "Solid Tumor Oncology Division"
  3. "Department of Medicine"
  4. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (37)
  2. Meeting Abstract (27)
  3. Correspondence (1)
Groups
  1. Department of Medicine (65)
  2. Epidemiology and Biostatistics (65)
  3. Solid Tumor Oncology Division (65)
  4. Thoracic Oncology (65)
  5. Biostatistics Service (55)
  6. GSK Faculty (46)

More Groups

People
  1. Alexander Drilon (65)
  2. Bob Li (35)
  3. Maria Arcila (31)
  4. Charles Rudin (30)
  5. Mark Kris (25)
  6. Michael Offin (23)

More People

Years
  1. 2024 (1)
  2. 2023 (6)
  3. 2022 (10)
  4. 2021 (8)
  5. 2020 (6)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Clinical Cancer Research (8)
  3. Journal of Thoracic Oncology (7)
  4. JCO Precision Oncology (4)
  5. Annals of Oncology (3)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (24)
  2. American Association for Cancer Research (12)
  3. Elsevier Inc. (12)
  4. Oxford University Press (5)
  5. Elsevier Ireland Ltd. (3)
  6. Wiley Blackwell (3)

More Publishers

Results (65)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Genomic characterization of FGFR-altered solid tumors using a clinically annotated pan-cancer repository
    Meeting Abstract

    Choudhury, N. J.; Harada, G.; Whiting, K.; Shen, R.; Yang, S. R.; Solit, D. B.; Berger, M. F.; Dinapoli, S.; Abou-Alfa, G. K.; Iyer, G.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Quantifying the growth of clinical actionability in precision oncology using OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Zhang, H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Central nervous system disease in patients with RET fusion-positive NSCLC treated with selpercatinib
    Journal Article

    Murciano-Goroff, Y. R.; Falcon, C. J.; Lin, S. T.; Chacko, C.; Grimaldi, G.; Liu, D.; Wilhelm, C.; Iasonos, A.; Drilon, A.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • In reply to “Selpercatinib controls central nervous system disease in patients with RET fusion-positive NSCLC”
    Correspondence

    Murciano-Goroff, Y. R.; Lin, S. T.; Wilhelm, C.; Iasonos, A.; Drilon, A.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of central nervous system clinico-genomic outcomes in ALK-positive non-small cell lung cancer patients with brain metastases treated with alectinib
    Journal Article

    Miao, E.; Eichholz, J. E.; Lebow, E. S.; Flynn, J.; Zhang, Z.; Walch, H.; Hubbeling, H.; Beal, K.; Moss, N. S.; Yu, K. K.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • OncoKB, MSK's precision oncology knowledge base
    Meeting Abstract

    Suehnholz, S. P.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; Ladanyi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic alterations in ALK fusion-positive non-small cell lung cancer (NSCLC) patients with brain metastases
    Meeting Abstract

    Eichholz, J.; Miao, E.; Lebow, E.; Walch, H.; Flynn, J.; Zhang, Z.; Hubbeling, H.; Beal, K.; Moss, N.; Yu, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save